No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
TG Therapeutics Price Target Raised to $10 From $9 at BofA
BofA Securities Adjusts Price Target on TG Therapeutics to $10 From $9, Maintains Underperform Rating
Express News | TG Therapeutics Inc : BofA Global Research Raises Price Objective to $10 From $9
Jefferies Sticks to Their Buy Rating for TG Therapeutics (TGTX)
Investors in TG Therapeutics (NASDAQ:TGTX) Have Seen Splendid Returns of 185% Over the Past Five Years